Serum India, Bharat Biotech to test intranasal COVID-19 vaccines post regulatory nod: Dr Harsh… EP News Bureau Oct 19, 2020 He clarified that Phase III clinical trial is generally with thousands of participants, sometimes even close to 30,000 to 40,000…
‘Our vision at Navitas is to be the best knowledge company in the Life Sciences R&D space’ EP News Bureau Mar 23, 2015 Information technology has become a crucial part of pharma industry helping it streamline itself. TAKE solutions has recognised…
